澳门永利集团手机版

  1. 公司简介
    关于永利 >公司简介

         广西永利药业股份有限公司创于1988年,前身为广西桂北制药厂,2002年改制后更名为广西永利药业,公司目前已拥有总资产2.8亿元,占地面积80亩已通过国家新版GMP认证的现代化制药工业基地和一个2000亩的槐米标准化种植基地(正力争通过国家GAP认证),员工500多人。
         公司目前主要从事中药保健品、中成药制剂、药酒、化学药品制剂及功能性食品的开发、生产和销售,以及中药材的种植与经营。公司产品包括抗病毒药、抗感染药、心脑血管药、广谱抗菌药、妇科用药、保健食品等众多品类产品,已上市产品20多个,其中主要终端推广品种有:永利喉痛灵颗粒、永利澳门永利手机版、永利小儿感冒颗粒、妇嫝媬南珍液体安全套等产品。均以其确切的疗效和良好的品牌形象畅销各地市场。
         农业高新技术桂北金槐提取芦丁系列产品项目。公司通过开发种植2000亩标准化种植基地,带动桂林市县两万余户农民计划种植桂北金槐二十万亩,现已成为全国最大的槐米种植基地及加工基地。
    为顺应国家对药材供应的GAP认证要求,公司已经着手在全州县推动投资1亿元人民币的永利中草药基地项目,目标是3年内建立永利药业自己的药品原材料供应基地,并通过国家的GAP认证。永利已再投资1.3亿元,新建的芦丁原料药生产线,成为亚洲最大的芦丁提取生产企业。
         广西永利药业股份有限公司先后被评为:国家高新技术企业、广西扶贫龙头企业、桂林市农业产业化龙头企业、广西百强企业、桂林市纳税十佳模范、广西信用优良企业,永利澳门永利手机版、永利喉痛灵颗粒获国家知名品牌,银行信用等级AA,广西著名商标。
         公司通过长线经营“永利”“壮方”品牌,立志成为中国医药行业独具特色的现代药业企业。

          Chan Fang Pharmaceutical Co., Ltd. Guangxi was established in 1988. The company currently has assets of280 million yuan, covers an area of 80 mu modern pharmaceutical industry base which has been passed the national new GMP certification, and a 2000 mu standardized planting base of sophora japonica (are applying for the national GAP certification).There are more than 500 employees in Chan Fang.
         The company is mainly engaged in Chinese medicine health care products, Chinese patent medicine preparations, medicinal liquor, chemical medicine preparations and functional food development, production and
    sales, as well as the Chinese herbal medicine planting and management.Company products include antiviral drugs, anti-infective drugs, cardiovascular drugs, broad-spectrum antibiotic drugs, gynecological drugs, healthfoods, and many other categories. There are more than 20 kinds of products in the market, the main terminal promotion products are: Chan Fang Houtongling granules, Chan Fang Guciping tablet, Chan Fang children cold
    granules, Nanzhenfukang liquid condom, etc. The company has the best-selling across the market with its exactcurative effect and good brand image.
        The agricultural high-tech project Jin Huai series products program.Company has developed 2000 mu
    standardized planting base, driving more than twenty thousand farmers plant Gui Bei Jin Huai for one hundred thousand mu, which will become the largest sophora japonica planting base and processing base in
    China.
          To comply with the national GAP certification requirements of medicinal materials supply, the company hasbegun promoting an investment of RMB 100 million yuan of Chan Fang herbal medicine base project in Quanzhou, the goal is to establish Chan Fang pharmaceutical raw materials supply base and pass the national GAP certification in three years. Company has been the largest Rutin extraction manufacturer since it invested 130 million yuan to complete raw materials of Rutin production lines.
         The company has been evaluated: national high and new technology enterprise, poverty alleviation leading enterprise in Guangxi, agricultural industrialization leading enterprise in Guilin, top hundred enterprise in Guangxi, top ten model enterprises of taxing, excellent credit enterprise in guangxi, China's famous brand, AA grade bank
    credit enterprise, high and new technology enterprise in guangxi.
    The company devotes to be a unique modern pharmaceutical enterprise in China's pharmaceutical industry by long term operation of "Chan Fang" brand .